Description

BSE lists 26,69,951 new equity shares of Astec Lifesciences Limited issued on rights basis, effective July 31, 2025.

Summary

BSE has approved the listing of 26,69,951 new equity shares of Astec Lifesciences Limited (Scrip Code: 533138) issued through a rights offering. The shares will commence trading on July 31, 2025.

Key Points

  • 26,69,951 equity shares of Rs. 10/- each issued at premium of Rs. 880/-
  • Rights basis issuance with allotment date of July 29, 2025
  • ISIN: INE563J01010
  • Distribution numbers: 19611711 to 22281661
  • Shares rank pari-passu with existing equity shares

Regulatory Changes

No regulatory changes introduced.

Compliance Requirements

Trading members are informed of the new securities availability for trading.

Important Dates

  • Allotment Date: July 29, 2025
  • Trading Commencement: July 31, 2025

Impact Assessment

The rights issue increases Astec Lifesciences’ share capital and provides existing shareholders with additional equity participation. The premium pricing at Rs. 880/- suggests strong market confidence in the company’s prospects.

Impact Justification

Rights issue listing affects existing shareholders and increases share capital but is routine corporate action